Adherence patterns in antiseizure medications influencing risk of sudden unexplained death in epilepsy: A data linkage study using dispensed prescriptions

Medication adherence is considered an important risk factor for sudden unexpected death in epilepsy (SUDEP), although measurement accuracy is difficult. Using prescription dispensations, this study aims to estimate antiseizure medication (ASM) adherence and identify adherence patterns that influence epilepsy mortality.

[1]  Wesley T. Kerr,et al.  Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy , 2021, Epilepsia.

[2]  Josemir W Sander,et al.  FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force , 2021, Epilepsia open.

[3]  K. Matthews,et al.  Medication adherence, utilization of healthcare services, and mortality of patients with epilepsy on opiate replacement therapy: A retrospective cohort study , 2021, Epilepsy & Behavior.

[4]  C. Elger,et al.  Does the accumulated antiepileptic drug load in chronic epilepsy reflect disease severity? , 2020, Epilepsia.

[5]  J. Hallas,et al.  Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling , 2020, Pharmacoepidemiology and drug safety.

[6]  J. Hung,et al.  Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patients , 2020, Pharmacoepidemiology and drug safety.

[7]  S. Patten,et al.  Association of Levels of Specialized Care With Risk of Premature Mortality in Patients With Epilepsy. , 2019, JAMA neurology.

[8]  Dan Dediu,et al.  Beyond Adherence Thresholds: A Simulation Study of the Optimal Classification of Longitudinal Adherence Trajectories From Medication Refill Histories , 2019, Front. Pharmacol..

[9]  M. Hiligsmann,et al.  Methods for Measuring Multiple Medication Adherence: A Systematic Review-Report of the ISPOR Medication Adherence and Persistence Special Interest Group. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  J. Hung,et al.  Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database , 2018, Clinical epidemiology.

[11]  E. Roughead,et al.  The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System , 2018, BMJ Open.

[12]  D. Friedman,et al.  Underestimation of sudden deaths among patients with seizures and epilepsy , 2017, Neurology.

[13]  T. Tomson,et al.  The incidence of SUDEP , 2017, Neurology.

[14]  N. Malek,et al.  A review of medication adherence in people with epilepsy , 2017, Acta neurologica Scandinavica.

[15]  Dan Dediu,et al.  Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data , 2017, PloS one.

[16]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[17]  Orrin Devinsky,et al.  Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention , 2016, The Lancet Neurology.

[18]  H. Hamer,et al.  Nonadherence to antiepileptic drugs in Germany , 2016, Neurology.

[19]  S. Pearson,et al.  The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers , 2015, BMC Research Notes.

[20]  D. Thurman,et al.  Sudden unexpected death in epilepsy: Assessing the public health burden , 2014, Epilepsia.

[21]  R. Horne,et al.  Patients' perspectives on antiepileptic medication: Relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care , 2014, Epilepsy & Behavior.

[22]  I. Abraham,et al.  A method for calculating adherence to polypharmacy from dispensing data records , 2013, International Journal of Clinical Pharmacy.

[23]  A. Schulze-Bonhage,et al.  Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study , 2013, The Lancet Neurology.

[24]  V. Allgar,et al.  Adherence to medicines and self-management of epilepsy: A community-based study , 2013, Epilepsy & Behavior.

[25]  Maochao Xu,et al.  Comparison of pharmacy-based measures of medication adherence , 2012, BMC Health Services Research.

[26]  R. Bautista,et al.  Effects of antiepileptic drug characteristics on medication adherence , 2012, Epilepsy & Behavior.

[27]  P. Ryvlin,et al.  Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials , 2011, The Lancet Neurology.

[28]  Josemir W Sander,et al.  Combined analysis of risk factors for SUDEP , 2011, Epilepsia.

[29]  Samden D Lhatoo,et al.  An electroclinical case‐control study of sudden unexpected death in epilepsy , 2010, Annals of neurology.

[30]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[31]  Josemir W. Sander,et al.  Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms , 2009, Nature Reviews Neurology.

[32]  S. Candrilli,et al.  Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy , 2009, Epilepsy & Behavior.

[33]  E. Faught,et al.  Nonadherence to antiepileptic drugs and increased mortality , 2008, Neurology.

[34]  Philippe Ryvlin,et al.  Sudden unexpected death in epilepsy: current knowledge and future directions , 2008, The Lancet Neurology.

[35]  Josemir W Sander,et al.  Sudden Unexpected Death in Epilepsy A Personalized Prediction Tool , 2022 .